BackCaribou Biosciences Overview

Caribou Biosciences Receivables

Latest receivables for CRBU: $1.2M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.17M
↓ 43.72% YoYΔ $-905000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Caribou Biosciences Receivables History

Loading

Caribou Biosciences vs. peers: Receivables Comparison

Loading

Caribou Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Caribou Biosciences (CRBU) FAQ

As of the most recent data (September 2026), CRBU shows a receivables of $1.2M. That compares with $2.1M in the prior-year period — down 43.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRBU's receivables is now $1.2M (was $2.1M) — a 43.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Caribou Biosciences is outperforming or lagging.

Tracking CRBU's receivables over time shows whether Caribou Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $2.1M in the prior-year period — down 43.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Caribou Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.2M) with ownership activity and broader fundamentals.

Caribou Biosciences's receivables is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.